Posted in | News | Medical Sensor

Masimo’s Blue Sensor Can Benefit Cyanotic Children with Congenital Heart Disease

Masimo announced today that a new study reported on the accuracy of Masimo’s Blue® sensors as compared to Nellcor and Masimo Standard sensors for cyanotic children with blood oxygen saturation less than 85%. Masimo’s Blue sensor was designed specifically for cyanotic infants and children with congenital heart disease.

The study was performed at the Lucile Packard Children’s Hospital at Stanford University with the aim of determining, in children with cyanotic congenital heart disease, which of three different pulse oximeter sensors is the most accurate at lower blood oxygen saturation levels, when compared to the “gold standard” of arterial blood gas analysis with CO-oximetry. The three sensors were Masimo SET® with LNCS® sensor (Masimo Standard), Masimo SET® with Blue sensor (Masimo Blue), and Nellcor™ N-600 with MAX-I sensor (Nellcor).

In the study, published in the journal Pediatric Critical Care Medicine, Dr. Harris and colleagues collected data from 50 infants and children weighing 3–20 kg with baseline saturations under 90% (measured by pulse oximetry at the time of clinical assessment) undergoing surgical or catheterization procedures. Following standard care monitoring, which included placement of the Masimo Standard sensor, the Masimo Blue and Nellcor MAX-I sensors were placed on a thumb or great toe, or alternatively on a finger. Up to four arterial blood samples were taken from each subject.

Compared to the CO-oximeter saturations (SaO2) over all measurements, the mean error ± standard deviation of the saturation values from pulse oximetry (SpO2) for the Masimo Blue, Nellcor, and Masimo Standard sensors were 1.7% ± 3.3%, 1.7% ± 5.4%, and 2.4% ± 4.9%, respectively.

The investigators concluded that “the Masimo Blue sensor has improved accuracy at saturations 75–85% versus the Nellcor and Masimo Standard sensors,” although the authors noted inaccuracies with all three sensors in this saturation range. The authors suggested there is a continued need for device manufacturers to calibrate and develop algorithms for pulse oximeters to have improved overall accuracy at saturations less than 85%. The authors further stated “clinical decisions at saturations below 85% should not be made by pulse oximetry alone; instead, co-oximetry and/or an arterial blood gas is warranted.”

Study limitations included small sample size, difficulty collecting steady-state samples from the operating room and catheterization lab, and placement of the Masimo Standard sensor in nonstandard locations.

The institution where this study was performed received a grant from Masimo to partially support the data collection for this study.

Source: http://www.masimo.com

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Masimo Corporation. (2019, February 24). Masimo’s Blue Sensor Can Benefit Cyanotic Children with Congenital Heart Disease. AZoSensors. Retrieved on May 21, 2024 from https://www.azosensors.com/news.aspx?newsID=10957.

  • MLA

    Masimo Corporation. "Masimo’s Blue Sensor Can Benefit Cyanotic Children with Congenital Heart Disease". AZoSensors. 21 May 2024. <https://www.azosensors.com/news.aspx?newsID=10957>.

  • Chicago

    Masimo Corporation. "Masimo’s Blue Sensor Can Benefit Cyanotic Children with Congenital Heart Disease". AZoSensors. https://www.azosensors.com/news.aspx?newsID=10957. (accessed May 21, 2024).

  • Harvard

    Masimo Corporation. 2019. Masimo’s Blue Sensor Can Benefit Cyanotic Children with Congenital Heart Disease. AZoSensors, viewed 21 May 2024, https://www.azosensors.com/news.aspx?newsID=10957.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.